ATRC
HEALTHCAREAtricure Inc
$28.01-1.38 (-4.70%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving ATRC Today?
No stock-specific AI insight has been generated for ATRC yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$26.62$43.18
$28.01
Fundamentals
Market Cap$1.4B
P/E Ratio—
EPS$-0.10
Dividend Yield—
Dividend / Share—
ROE-0.0%
Profit Margin-0.0%
Debt / Equity—
Trading
Volume1.2M
Avg Volume (10D)—
Shares Outstanding50.6M
ATRC News
20 articles- AtriCure (ATRC) Q1 2026 Earnings TranscriptMotley Fool·May 6, 2026
- AtriCure, Inc. Q1 2026 Earnings Call SummaryMoby·May 6, 2026
- Here's What Key Metrics Tell Us About AtriCure (ATRC) Q1 EarningsYahoo Finance·May 6, 2026
- AtriCure Q1 Earnings Call HighlightsMarketbeat·May 5, 2026
- AtriCure (ATRC) Reports Break-Even Earnings for Q1Yahoo Finance·May 5, 2026
- AtriCure Reports First Quarter 2026 Financial ResultsYahoo Finance·May 5, 2026
- AtriCure (ATRC) Slid Despite Strong EarningsYahoo Finance·May 5, 2026
- AtriCure to Participate in the 2026 Bank of America Securities Health Care ConferenceYahoo Finance·Apr 28, 2026
- AtriCure to Announce First Quarter 2026 Financial ResultsYahoo Finance·Apr 14, 2026
- Assessing AtriCure (ATRC) Valuation After Prolonged Share Price WeaknessYahoo Finance·Apr 9, 2026
- AdaptHealth (AHCO) Surges 10.7%: Is This an Indication of Further Gains?Yahoo Finance·Mar 25, 2026
- This $6.5 Million Healthcare Trim Comes Amid a 71% Stock Surge and 20% Revenue GrowthMotley Fool·Mar 22, 2026
- This $8.9 Million Buy Targets a Stock Down 68% With $322 Million in CashMotley Fool·Mar 22, 2026
- DAFNA Capital Trims iShares Biotechnology ETF Within Broader Biotech Portfolio, According to Recent SEC FilingMotley Fool·Mar 21, 2026
- AtriCure CSO Sells 5,000 Shares — A Modest Trim or a Pattern Worth Watching?Motley Fool·Mar 18, 2026
- AtriCure CFO Sees 12%-14% Organic Growth in 2026 as Pain Management Adoption AcceleratesMarketbeat·Mar 11, 2026
- Will AtriCure’s (ATRC) 2026 Profitability Guidance Mark a Turning Point in Its Investment Narrative?Yahoo Finance·Mar 2, 2026
- AtriCure to Participate in the Citizens Life Sciences ConferenceYahoo Finance·Feb 24, 2026
- GEHC Expands BARDA Collaboration With $35M Boost for AI UltrasoundYahoo Finance·Feb 18, 2026
- Can OPKO Health's Pipeline Progress and Deals Drive Growth in 2026?Yahoo Finance·Feb 18, 2026
All 20 articles loaded
Price Data
Open$28.73
Previous Close$29.39
Day High$29.55
Day Low$28.02
52 Week High$43.18
52 Week Low$26.62
52-Week Range
$26.62$43.18
$28.01
Fundamentals
Market Cap$1.4B
P/E Ratio—
EPS$-0.10
Dividend Yield—
Dividend / Share—
ROE-0.0%
Profit Margin-0.0%
Debt / Equity—
Trading
Volume1.2M
Avg Volume (10D)—
Shares Outstanding50.6M
About Atricure Inc
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems to medical centers in the United States, Europe, Asia, and internationally. The company is headquartered in Mason, Ohio.
HEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICMEDICAL INSTRUMENTS & SUPPLIES
CIK—
Composite FIGI—
Share Class FIGI—